WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

A Spanish biotech banks $87M to make differentiated ADCs

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

Raccontata dabiopharmadive.comlavanguardia.comendpoints.news

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
biopharmadive.comStai leggendo1 mesi fa

A Spanish biotech banks $87M to make differentiated ADCs

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

originale
endpoints.news1 mesi fa

ADC biotech Ona Therapeutics secures $86.6M in Series B raise

Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 4 giugno 2026·biopharmadive.com

    A Spanish biotech banks $87M to make differentiated ADCs

    Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced forms of breast and colorectal cancers.

  2. giovedì 4 giugno 2026·lavanguardia.com

    Ona Therapeutics consigue 74 millones para avanzar en sus fármacos contra el cáncer

    La compañía destinará buena parte de los recursos a los ensayos clínicos de su molécula estrella

lavanguardia.com1 mesi fa

Ona Therapeutics consigue 74 millones para avanzar en sus fármacos contra el cáncer

La compañía destinará buena parte de los recursos a los ensayos clínicos de su molécula estrella

Leggi questa versione → originale
  • giovedì 4 giugno 2026·endpoints.news

    ADC biotech Ona Therapeutics secures $86.6M in Series B raise

    Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic.